Home
Injectable medicines for in-vitro dia...

Injectable medicines for... Market Share Analysis for November 2025

Aguettant Corporate - Official Website - Injectable medicines: diversification of in-vitro diagnostics. Dedicated solutions for biotherapy and CBRN risks.

Industry: N/A

Domainaguettant-corporate.com

Year Founded--

Employees501 - 1000

Annual Revenue--

Injectable medicines for in-vitro dia...

Injectable medicines for in-vitro dia... (including company regionals)

aguettant-corporate.com

See more website traffic and engagement information

Total visits to Injectable medicines for in-vitro dia...'s top domains

Understand Injectable medicines for in-vitro dia... market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

aguettant-corporate.com985

See more with Sales Intelligence

Avg. visit duration in Injectable medicines for in-vitro dia...'s top domains

Analyze Injectable medicines for in-vitro dia... engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

aguettant-corporate.com00:01:10

See more with Sales Intelligence

Avg. pageviews on Injectable medicines for in-vitro dia...'s top domains

See how Injectable medicines for in-vitro dia... keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

aguettant-corporate.com2.27

See more with Sales Intelligence

Injectable medicines for in-vitro dia... top competitors by domain

Top similar sites in November 2025, ranked by their affinity

aguettant.frCompany NameAguettant InstitutEmployees501 - 1000HQFrance, LyonAnnual revenue$100M - $200MTotal visits1.5KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Injectable medicines for in-vitro dia...

These are the website technologies, by industry, used by Injectable medicines for in-vitro dia... top domains

Widget (3)

reCAPTCHA

Content Management System (2)

WordPress

Conversion & Analytics (2)

Matomo (Previously Piwik)

Mobile (2)

Meta Viewport

More Technologies

8

See all

News & Signals from Injectable medicines for in-vitro dia...

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAguettant Group received award Bronze medal on Mar 1st '24.EcoVadis awarded Aguettant a Bronze medal in March 2024.

NewsAguettant Group launched DZUVEO in Europe on Oct 14th '22.Our European partner, Aguettant, recently launched DZUVEO® in Europe, further extending the commercial footprint of our novel sufentanil sublingual tablet."

NewsHyloris Pharmaceuticals SA partners with Aguettant Group.Hyloris has secured licensing deals with Aguettant for its Maxigesic IV combination of paracetamol and ibuprofen in a further eight European markets through partner AFT Pharmaceuticals.